| Ytd | 19.83% | |
| 1y | -28.72% |
| Open | 1.30 | Prev Close | 1.28 | Low | 1.27 | High | 1.40 | Mkt Cap | 12.07M |
| Vol | 204.86K | Avg Vol | 4.60M | EPS | -3.05 | P/E | N/A | Forward P/E | -0.49 |
| Beta | 0.90 | Short Ratio | 0.15 | Inst. Own | 9.99% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 11-09 | 50-d Avg | 1.68 | 200-d Avg | 1.52 | 1yr Est | 5.00 |
BIVI News
BioVie (NASDAQ: BIVI) outlined Phase II results for its investigational drug bezisterim in Long COVI
BioVie Inc. (BIVI) Discussion of Phase 2 data on bezisterim in Long COVID and Parkinson's with focus
BioVie Inc. (BIVI) Discusses Topline Phase 2 ADDRESS-LC Trial Data and the Potential of Bezisterim i
Clinical-stage biopharmaceutical firm BioVie Inc. (NASDAQ:BIVI) stock is trading lower after the com
BioVie reported Phase 2 ADDRESS-LC trial results evaluating bezisterim for Long COVID, showing signi
Statistically significant benefits observed in bezisterim-treated Long COVID patients in pre-specifi
Statistically significant benefits observed in bezisterim-treated Long COVID patients in pre-specif
Conference call scheduled for Tuesday, September 15, 2026, at 8:30 a.m. Eastern Time (ET) Conference
On September 11, 2026, BioVie Inc., a Nevada corporation (the "Company"), entered into a sal
4:15pm: Oil spike hits stocks US stocks closed sharply lower on Tuesday as surging oil prices revive
BioVie Inc (NASDAQ:BIVI, NASDAQ:BIVIW) told investors that it is preparing to advance its Phase 3 de
BioVie Inc. (NASDAQ: BIVI) ("BioVie" or the "Company"), a clinical-stage company dev
Company Corresponded with the FDA on an End of Phase 2 Meeting to Align on Phase 3 trial Design for
Gainers Redhill Biopharma (NASDAQ:RDHL) stock increased by 69.4% to $1.12 during Monday's regul
3:40pm: Small cap wrap BioVie Inc (NASDAQ:BIVI, NASDAQ:BIVIW) has completed the final on-treatment v
BioVie Inc (NASDAQ:BIVI, NASDAQ:BIVIW) announced that has completed the last on-treatment visit in i
BioVie Inc (NASDAQ:BIVI, NASDAQ:BIVIW) announced that has completed the last on-treatment visit in i
CARSON CITY, Nev., Aug. 31, 2026 (GLOBE NEWSWIRE) -- BioVie Inc. (NASDAQ: BIVI) (“BioVie” or the “Co
Gainers Werewolf Therapeutics (NASDAQ:HOWL) shares moved upwards by 74.6% to $0.75 during Friday
Gainers Indaptus Therapeutics (NASDAQ:INDP) shares moved upwards by 34.0% to $1.26 during Thursday&
Gainers Circle8 Group (NASDAQ:CIRC) shares increased by 18.2% to $0.77 during Thursday's pre-ma
Webull Corp (NASDAQ: BULL) rose sharply in pre-market trading after reporting better-than-expected Q
Gainers BioVie (NASDAQ:BIVI) stock increased by 15.7% to $1.55 during Wednesday's after-market
Gainers ZeroStack (NASDAQ:ZSTK) stock increased by 440.2% to $9.94 during Wednesday's regular s
Gainers Tenon Medical (NASDAQ:TNON) stock rose 122.5% to $12.13 during Wednesday's pre-market s
KEYS stock rose 3% in pre-market trading due to strong financial results and guidance. Other gainers
Gainers AIxCrypto Hldgs (NASDAQ:AIXC) stock increased by 132.0% to $1.65 during Tuesday's regul
BioVie (NASDAQ:BIVI) reported quarterly losses of $(0.70) per share. This is a 50.7 percent increase
BioVie Inc. (BIVI) Discusses Bezisterim Mechanism of Action and SUNRISE-PD Phase II Trial Design Tra
Gainers BioVie (NASDAQ:BIVI) shares increased by 39.4% to $1.77 during Wednesday's regular sess
For years, the hunt for a Parkinson's disease-modifying drug came down to one protein: alpha-synucle
Gainers AVITA Medical (NASDAQ:RCEL) stock rose 58.4% to $7.53 during Friday's regular session.
Vaalco Energy Inc (LSE:EGY) told investors that second-quarter sales jumped 47% from the previous th
Gainers Creative Medical Tech (NASDAQ:CELZ) stock increased by 107.8% to $1.39 during Thursday'
Apple Inc (NASDAQ:AAPL, XETRA:APC) App Store revenue rose 0.6% year-over-year in the first 35 days o
Uber Technologies Inc (NYSE:UBER, XETRA:UT8) saw its price target lowered to $101 from $103 by Bank
US stocks trade mixed, Nasdaq falls 50 points. Energy shares up 1.3%, tech stocks down 0.5%. US Food
BioVie Inc (NASDAQ:BIVI, NASDAQ:BIVIW) said its drug candidate bezisterim met the prespecified endpo
Gainers Creative Medical Tech (NASDAQ:CELZ) stock increased by 86.9% to $1.25 during Thursday's
Patients treated with bezisterim demonstrated statistically significant improvements compared to pla
Gainers Zhengye Biotechnology (NASDAQ:ZYBT) shares increased by 322.6% to $2.95 during Monday's
Gainers Advanced Biomed (NASDAQ:ADVB) shares rose 24.1% to $6.24 during Monday's pre-market ses
Eva Live gained 16.4% in pre-market trading after signing a letter of intent to acquire Airbeam Wire
Gainers Agenus (NASDAQ:AGEN) shares increased by 95.8% to $6.56 during Monday's regular session
-Topline Data Release Targeted Late Summer 2026-CARSON CITY, Nev., May 26, 2026 (GLOBE NEWSWIRE) --
"With this last patient's treatment visit completed, our team will start the study closeout
BioVie Inc. (NASDAQ: BIVI) ("BioVie" or the "Company"), a clinical-stage company dev